Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:469-472

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, D. J.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, D. J.
Right arrow Articles by Williams, G. H.

(Hypertension. 1998;31:469.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Impact of Dietary Na+ on Glycyrrhetinic Acid-Like Factors (Kidney 11ß-(HSD2)-GALFs) in Human Essential Hypertension

David J. Morris; Ying H. Lo; W. Reid Lichtfield; Gordon H. Williams

From the Department of Pathology and Laboratory Medicine, The Miriam Hospital, Brown University School of Medicine, Provideance, RI (D.J.M., Y.H.L.), and Department of Medicine, Brigham and Women’s Hospital, Boston, Mass (W.R.L., G.H.W.)

Correspondence to Dr. David J. Morris, Department of Pathology and Laboratory Medicine, The Miriam Hospital, 164 Summit Avenue, Providence, RI 02906. E-mail dmorris{at}rihosp.edu.

Our previous studies have shown that human urine contains glycyrrhetinic acid-like factors (GALFs) that possess inhibitory activity against kidney 11ß-hydroxysteroid dehydrogenase isoform 2 (HSD2). The present studies were undertaken to determine the impact of dietary Na+ intake on the levels of kidney 11ß(HSD2)-GALFs. The excretion of kidney 11ß(HSD2)-GALFs in 24-hour urine samples of 30 unmedicated subjects (10 normotensive and 10 high/normal-renin and 10 low-renin essential hypertensive subjects) on both 200- and 10-mmol Na+ diets was studied. No differences in the urinary levels of kidney 11ß(HSD2)-GALFs were observed among the three groups on the high-Na+ diet. However, with a low-Na+ diet, the levels of kidney 11ß(HSD2)-GALFs were significantly increased in hypertensive subjects but not in normal subjects. Levels increased from 8.3±1.4 to 17.3±2.9 and 6.7±1.3 to 10.6±1.4 carbenoxolone sodium units/d in high/normal-renin (P=.01) and low-renin hypertensive subjects (P=.07), respectively; normal subjects changed from 8.0±1.9 to 10.6±2.4. The levels of kidney 11ß(HSD2)-GALFs were significantly higher in the high/normal-renin hypertensive subjects than in either the control normotensive subjects or the low-renin hypertensive subjects when challenged with the low-Na+ diet (P<.05 by Wilcoxon rank-sum test). The greater response of the high/normal-renin hypertensive subjects indicated that they may utilize kidney 11ß(HSD2)-GALFs when challenged with a low-Na+ diet, whereas the low-renin essential hypertensive subjects do not.


Key Words: licorice • 11 ß-hydroxysteroid dehydrogenase • glycyrrhetinic acid • glycyrrhetinic acid-like factors • hypertension

Abbreviations: CBX = carbenoxolone sodium • GALF = glycyrrhetinic acid-like factor • HSD1, HSD2 = hydroxysteroid dehydrogenase isoform 1, isoform 2 • MR = mineralocorticoid receptor




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. W. Kim, S. de Seigneux, M. C. Sassen, J. Lee, J. Kim, M. A. Knepper, J. Frokiaer, and S. Nielsen
Increased apical targeting of renal ENaC subunits and decreased expression of 11betaHSD2 in HgCl2-induced nephrotic syndrome in rats
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F674 - F687.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Bocchi, S. Kenouch, M. Lamarre-Cliche, M. Muffat-Joly, M. H. Capron, J. Fiet, G. Morineau, M. Azizi, J. P. Bonvalet, and N. Farman
Impaired 11-{beta} Hydroxysteroid Dehydrogenase Type 2 Activity in Sweat Gland Ducts in Human Essential Hypertension
Hypertension, April 1, 2004; 43(4): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Vogt, B. Dick, H.-P. Marti, F. J. Frey, and B. M. Frey
Reduced 11{beta}-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome
Nephrol. Dial. Transplant., May 1, 2002; 17(5): 753 - 758.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Lovati, P. Ferrari, B. Dick, K. Jostarndt, B. M. Frey, F. J. Frey, U. Schorr, and A. M. Sharma
Molecular Basis of Human Salt Sensitivity: The Role of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3745 - 3749.
[Abstract] [Full Text] [PDF]